Literature DB >> 10232607

Poly(ADP-ribosyl)ation of p53 during apoptosis in human osteosarcoma cells.

C M Simbulan-Rosenthal1, D S Rosenthal, R Luo, M E Smulson.   

Abstract

Spontaneous apoptosis in human osteosarcoma cells was observed to be associated with a marked increase in the intracellular abundance of p53. Immunoprecipitation and immunoblot analysis revealed that, together with a variety of other nuclear proteins, p53 undergoes extensive poly(ADP-ribosyl)ation early during the apoptotic program in these cells. Subsequent degradation of poly(ADP-ribose) (PAR), attached to p53 presumably by PAR glycohydrolase, the only reported enzyme to degrade PAR, was apparent concomitant with the onset of proteolytic processing and activation of caspase-3, caspase-3-mediated cleavage of poly(ADP-ribose) polymerase (PARP), and internucleosomal DNA fragmentation during the later stages of cell death. The decrease in PAR covalently bound to p53 also coincided with the marked induction of expression of the p53-responsive genes bax and Fas. These results suggest that poly(ADP-ribosyl)ation may play a role in the regulation of p53 function and implies a regulatory role for PARP and/or PAR early in apoptosis.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10232607

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  25 in total

Review 1.  Dial 9-1-1 for p53: mechanisms of p53 activation by cellular stress.

Authors:  M Ljungman
Journal:  Neoplasia       Date:  2000 May-Jun       Impact factor: 5.715

2.  Base excision repair is efficient in cells lacking poly(ADP-ribose) polymerase 1.

Authors:  M D Vodenicharov; F R Sallmann; M S Satoh; G G Poirier
Journal:  Nucleic Acids Res       Date:  2000-10-15       Impact factor: 16.971

3.  Disruption of poly(ADP-ribosyl)ation mechanisms alters responses of Arabidopsis to biotic stress.

Authors:  Lori Adams-Phillips; Amy G Briggs; Andrew F Bent
Journal:  Plant Physiol       Date:  2009-11-04       Impact factor: 8.340

4.  Failure to degrade poly(ADP-ribose) causes increased sensitivity to cytotoxicity and early embryonic lethality.

Authors:  David W Koh; Ann M Lawler; Marc F Poitras; Masayuki Sasaki; Sigrid Wattler; Michael C Nehls; Tobias Stöger; Guy G Poirier; Valina L Dawson; Ted M Dawson
Journal:  Proc Natl Acad Sci U S A       Date:  2004-12-10       Impact factor: 11.205

5.  Small molecule inhibitors of Wnt/beta-catenin/lef-1 signaling induces apoptosis in chronic lymphocytic leukemia cells in vitro and in vivo.

Authors:  Rajesh Kumar Gandhirajan; Peter Anton Staib; Katharina Minke; Iris Gehrke; Günther Plickert; Axel Schlösser; Esther Katharina Schmitt; Michael Hallek; Karl-Anton Kreuzer
Journal:  Neoplasia       Date:  2010-04       Impact factor: 5.715

Review 6.  Poly(ADP-ribose) polymerase: the nuclear target in signal transduction and its role in brain ischemia-reperfusion injury.

Authors:  Robert Piotr Strosznajder; Henryk Jesko; Agata Zambrzycka
Journal:  Mol Neurobiol       Date:  2005       Impact factor: 5.590

7.  DNA excision repair and DNA damage-induced apoptosis are linked to Poly(ADP-ribosyl)ation but have different requirements for p53.

Authors:  R Beneke; C Geisen; B Zevnik; T Bauch; W U Müller; J H Küpper; T Möröy
Journal:  Mol Cell Biol       Date:  2000-09       Impact factor: 4.272

8.  Role of nicotinamide in DNA damage, mutagenesis, and DNA repair.

Authors:  Devita Surjana; Gary M Halliday; Diona L Damian
Journal:  J Nucleic Acids       Date:  2010-07-25

9.  Inhibition of poly(ADP-ribose) polymerase activity is insufficient to induce tetraploidy.

Authors:  C M Simbulan-Rosenthal; D S Rosenthal; R Luo; J H Li; J Zhang; M E Smulson
Journal:  Nucleic Acids Res       Date:  2001-02-01       Impact factor: 16.971

10.  Protection by antioxidants against toxicity and apoptosis induced by the sulphur mustard analog 2-chloroethylethyl sulphide (CEES) in Jurkat T cells and normal human lymphocytes.

Authors:  Suhua Han; Luis A Espinoza; Hongling Liao; A Hamid Boulares; Mark E Smulson
Journal:  Br J Pharmacol       Date:  2004-02-09       Impact factor: 8.739

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.